Free Trial

Prestige Consumer Healthcare (PBH) Competitors

Prestige Consumer Healthcare logo
$62.97 -0.63 (-0.98%)
Closing price 09/23/2025 03:59 PM Eastern
Extended Trading
$63.03 +0.06 (+0.09%)
As of 04:47 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PBH vs. IPAR, HLF, NUS, USNA, NATR, MED, VERU, EL, BAX, and BIO

Should you be buying Prestige Consumer Healthcare stock or one of its competitors? The main competitors of Prestige Consumer Healthcare include Interparfums (IPAR), Herbalife (HLF), Nu Skin Enterprises (NUS), USANA Health Sciences (USNA), Nature's Sunshine Products (NATR), MEDIFAST (MED), Veru (VERU), Estee Lauder Companies (EL), Baxter International (BAX), and Bio-Rad Laboratories (BIO).

Prestige Consumer Healthcare vs. Its Competitors

Prestige Consumer Healthcare (NYSE:PBH) and Interparfums (NASDAQ:IPAR) are both mid-cap personal products companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability, institutional ownership and media sentiment.

Prestige Consumer Healthcare presently has a consensus price target of $96.80, indicating a potential upside of 53.71%. Interparfums has a consensus price target of $162.00, indicating a potential upside of 58.87%. Given Interparfums' stronger consensus rating and higher probable upside, analysts plainly believe Interparfums is more favorable than Prestige Consumer Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Prestige Consumer Healthcare
1 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.33
Interparfums
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

Prestige Consumer Healthcare has a beta of 0.46, meaning that its share price is 54% less volatile than the S&P 500. Comparatively, Interparfums has a beta of 1.44, meaning that its share price is 44% more volatile than the S&P 500.

In the previous week, Prestige Consumer Healthcare had 15 more articles in the media than Interparfums. MarketBeat recorded 16 mentions for Prestige Consumer Healthcare and 1 mentions for Interparfums. Interparfums' average media sentiment score of 1.42 beat Prestige Consumer Healthcare's score of 0.53 indicating that Interparfums is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Prestige Consumer Healthcare
5 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Interparfums
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Prestige Consumer Healthcare pays an annual dividend of $1.90 per share and has a dividend yield of 3.0%. Interparfums pays an annual dividend of $3.20 per share and has a dividend yield of 3.1%. Prestige Consumer Healthcare pays out 44.6% of its earnings in the form of a dividend. Interparfums pays out 64.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Interparfums has increased its dividend for 4 consecutive years. Interparfums is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Prestige Consumer Healthcare has a net margin of 19.02% compared to Interparfums' net margin of 11.03%. Interparfums' return on equity of 16.45% beat Prestige Consumer Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Prestige Consumer Healthcare19.02% 12.69% 6.79%
Interparfums 11.03%16.45%11.14%

99.9% of Prestige Consumer Healthcare shares are held by institutional investors. Comparatively, 55.6% of Interparfums shares are held by institutional investors. 1.4% of Prestige Consumer Healthcare shares are held by company insiders. Comparatively, 43.7% of Interparfums shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Prestige Consumer Healthcare has higher earnings, but lower revenue than Interparfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Prestige Consumer Healthcare$1.12B2.77$214.60M$4.2614.78
Interparfums$1.46B2.24$164.36M$4.9920.43

Summary

Interparfums beats Prestige Consumer Healthcare on 13 of the 19 factors compared between the two stocks.

Get Prestige Consumer Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PBH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PBH vs. The Competition

MetricPrestige Consumer HealthcareMED PRODUCTS IndustryMedical SectorNYSE Exchange
Market Cap$3.13B$10.70B$5.76B$21.71B
Dividend YieldN/A1.90%5.53%3.52%
P/E Ratio14.7820.5976.0629.84
Price / Sales2.7738.02472.8260.84
Price / Cash12.2024.5937.4624.72
Price / Book1.703.4013.584.59
Net Income$214.60M$212.47M$3.29B$1.00B
7 Day Performance-1.39%0.14%1.83%0.64%
1 Month Performance-5.66%-2.71%4.02%2.77%
1 Year Performance-11.47%-10.38%77.05%14.49%

Prestige Consumer Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PBH
Prestige Consumer Healthcare
4.459 of 5 stars
$62.97
-1.0%
$96.80
+53.7%
-12.9%$3.13B$1.12B14.78540
IPAR
Interparfums
4.2385 of 5 stars
$106.18
-0.5%
$162.00
+52.6%
-15.6%$3.43B$1.45B21.28530Positive News
HLF
Herbalife
4.4213 of 5 stars
$9.28
-2.9%
$11.50
+23.9%
+19.7%$985.69M$4.99B2.938,600
NUS
Nu Skin Enterprises
3.8277 of 5 stars
$11.80
-2.0%
$6.88
-41.8%
+71.1%$595.95M$1.73B5.873,100News Coverage
Positive News
Gap Up
USNA
USANA Health Sciences
4.4035 of 5 stars
$29.93
-1.9%
$36.00
+20.3%
-23.9%$557.47M$854.50M16.631,700
NATR
Nature's Sunshine Products
3.8011 of 5 stars
$17.01
+0.3%
$20.50
+20.5%
+19.5%$299.10M$454.36M22.99850News Coverage
Positive News
MED
MEDIFAST
3.4899 of 5 stars
$14.21
+1.7%
$16.50
+16.1%
-25.1%$153.54M$602.46M44.41870
VERU
Veru
2.7008 of 5 stars
$3.54
+2.6%
$33.33
+841.6%
-56.7%$50.57M$16.89M-1.61230News Coverage
Positive News
EL
Estee Lauder Companies
4.2094 of 5 stars
$87.35
+4.4%
$88.55
+1.4%
+1.1%$30.10B$14.33B-27.8257,000Positive News
BAX
Baxter International
4.7956 of 5 stars
$23.78
-0.9%
$30.11
+26.6%
-41.4%$12.32B$10.64B-79.2738,000
BIO
Bio-Rad Laboratories
4.5411 of 5 stars
$280.57
+0.1%
$333.50
+18.9%
-13.5%$7.59B$2.57B23.927,700Positive News
Analyst Revision

Related Companies and Tools


This page (NYSE:PBH) was last updated on 9/24/2025 by MarketBeat.com Staff
From Our Partners